ADIPOQ and rheumatoid arthritis: That research documented independent, negative correlations between low adiponectin levels with atherogenic dyslipidemia and high plasma glucose levels, findings that are similar to those previously reported in individuals without RA disease, suggesting that low circulating adiponectin levels cluster with features of MetS that are implicated in RA atherogenesis [34].